Goldman's Blankfein to be treated for lymphoma

Goldman Sachs chief executive Lloyd Blankfein said Tuesday he will undergo treatment for lymphoma in the coming months but would continue to work.

Blankfein, 61, said he received the diagnosis last week following a biopsy after several weeks of not feeling well. His treatment will include chemotherapy over the next several months. He said the prognosis is good.

"Fortunately, my form of lymphoma is highly curable and my doctors' and my own expectation is that I will be cured," he said in a statement on the bank's website.

Blankfein said he will continue to work "substantially as normal," but will need to reduce some travel during the treatment period.

Chief executive since 2006, Blankfein is one of the most powerful and prominent executives on Wall Street. He led the prestigious bank through the 2008 financial crisis.

His announcement comes about 14 months after JPMorgan Chase CEO Jamie Dimon revealed he was being treated for throat cancer. Dimon also continued to work during that stretch, although he reduced some duties.

Lymphoma is a cancer that begins in cells of the lymph system. It is the most common blood cancer in the United States, estimated to represent about five percent of all new cancers diagnosed in 2014.

Blankfein's statement did not disclose the type of lymphoma he has.